他莫昔芬相关性脂肪性肝炎——三例报告
Tamoxifen-associated steatohepatitis--report of three cases.
作者信息
Pinto H C, Baptista A, Camilo M E, de Costa E B, Valente A, de Moura M C
机构信息
Department of Medicine, University Hospital Santa Maria, Lisbon, Portugal.
出版信息
J Hepatol. 1995 Jul;23(1):95-7. doi: 10.1016/0168-8278(95)80316-5.
PMID:8530816
Abstract
The authors describe three cases of tamoxifen-associated steatohepatitis, which resulted from a daily dosage of 20 mg used as the adjuvant treatment of breast carcinoma. Liver tests became normal after discontinuation of tamoxifen.
摘要
作者描述了三例他莫昔芬相关的脂肪性肝炎病例，这些病例是由于每日服用20毫克他莫昔芬作为乳腺癌辅助治疗所致。停用他莫昔芬后肝功能检查恢复正常。
Zotero 插件